Facilitation of cholinergic transmission by combined treatment of ondansetron with flumazenil after cortical cholinergic deafferentation

Neuropharmacology

Volumn 47, Issue 2, 2004, Pages 225-232

  Gil Bea, Francisco J ^a   Domínguez, Jon ^a   García Alloza, Mónica ^a   Marcos, Beatriz ^a   Lasheras, Berta ^a   Ramírez, María J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

192 IgG saporin; 5 HT3 receptors; Alzheimer's disease; GABAA receptors; Nucleus basalis magnocellularis

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; FLUMAZENIL; IMMUNOGLOBULIN G; ONDANSETRON; SAPORIN; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; TOXIN;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN PERFUSION; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DEAFFERENTATION; DEPOLARIZATION; FRONTAL CORTEX; GIANT CELL; MALE; MICROINJECTION; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ACETYLCHOLINE; AFFERENT PATHWAYS; ANIMALS; CEREBRAL CORTEX; DENERVATION; FLUMAZENIL; GABA AGONISTS; GABA MODULATORS; GRANISETRON; MALE; MUSCIMOL; ONDANSETRON; PARASYMPATHETIC NERVOUS SYSTEM; POTASSIUM; RATS; RATS, WISTAR; RECEPTORS, GABA-A; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; SYNAPTIC TRANSMISSION;

EID: 3042606363     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.03.014     Document Type: Article

References (44)

1. Alreja M. Excitatory actions of serotonin on GABAergic neurons of the medial septum and diagonal band of Broca. Synapse. 22:1996;15-27
2. 3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature. 338:1989;762-763
3. Barnes J.M., Barnes N.M., Costall B., Deakin J.F., Ironside J.W., Kilpatrick G.J., Naylor R.J., Rudd J.A., Simpson M.D., Slater P., et al. Identification and distribution of 5-HT3 recognition sites within the human brainstem. Neurosci. Lett. 111:1990;80-86
4. Baxter M.G., Bucci D.J., Sobel T.J., Williams M.J., Gorman L.K., Gallagher M. Intact spatial learning following lesions of basal forebrain cholinergic neurons. Neuroreport. 7:1996;1417-1420
5. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Annal. Biochem. 72:1976;248-254
6. Buhot M.C., Martin S., Segu L. Role of serotonin in memory impairment. Ann. Med. 32:2000;210-221
7. Cassel J.C., Jeltsch H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience. 69:1995;1-41
8. Cossette P., Umbriaco D., Zamar N., Hamel E., Descarries L. Recovery of choline acetyltransferase activity without sprouting of the residual acetylcholine innervation in adult rat cerebral cortex after lesion of the nucleus basalis. Brain Res. 630:1993;195-206
9. Costall B., Naylor R.J. Neuropharmacology of 5-HT3 receptors ligands. Baumgarten H.G., Göthert M. Serotonergic Neurons and 5-HTR Receptors in the CNS. 1997;408-436 Springer-Verlag, Berlin
10. 3 receptors and GABAergic neurons inhibiting acetylcholine release in rat entorhinal cortex slices. Brain Res. 801:1998;228-232
11. 3 receptor blockade in freely moving rats. Brain Res. 956:2002;81-85
12. Diez-Ariza M., Redondo C., García-Alloza M., Lasheras L., Del Río J., Ramírez M.J. Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats. Psychopharmacology (Berl). 169:2003;35-41
13. Eckenstein F.P., Baughman R.W., Quinn J. An anatomical study of cholinergic innervation in rat cerebral cortex. Neuroscience. 25:1988;457-474
14. Fadel J., Moore H., Sarter M., Bruno J.P. Trans-synaptic stimulation of cortical acetylcholine release after partial 192 IgG-saporin-induced loss of cortical cholinergic afferents. J. Neurosci. 16:1996;6592-6600
15. A receptor. Neuropharmacology. 35:1996;1243-1250
16. Goodin S., Cunningham R. 5-HT3-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile. Oncologist. 7:2002;424-436
17. 2+ antagonist nimodipine. Neuroscience. 101:2000;101-114
18. Heckers S., Ohtake T., Wiley R.G., Lappi D.A., Geula C., Mesulam M.M. Complete selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J. Neurosci. 14:1994;1271-1289
19. Herzog C.D., Nowak K.A., Sarter M., Bruno J.P. Microdialysis without acetylcholinesterase inhibition reveals an age-related attenuation in stimulated cortical acetylcholine release. Neurobiol. Aging. 24:2003;861-863
20. Inglis F. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int. J. Clin. Pract. Suppl. 127:2002;45-63
21. Lacalle S., Kukarni S., Wiley R.G. Lesion-induced transneuronal plasticity of the cholinergic innervation in the adult entorhinal cortex. Eur. J. Neurosci. 10:1998;1054-1062
22. Lapchak P.A., Hefti F. Effect of recombinant human nerve growth factor on presynaptic cholinergic function in rat hippocampal slices following partial septohippocampal lesions: measures of [3H]acetylcholine synthesis, [3H]acetylcholine release and choline acetyltransferase activity. Neuroscience. 42:1991;639-649
23. Lapchak P.A., Jenden D.J., Hefti F. Compensatory elevation of acetylcholine in vivo by cholinergic neurons surviving partial lesions of the septohippocampal pathway. J. Neurosci. 9:1991;2821-2828
24. 3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release. J. Neurochem. 58:1992;2334-2337
25. Mcgaughy J., Dalley J.W., Morrison C.H., Everitt B.J., Robbins T.W. Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-Saporin on attentional performance in a five-choice serial reaction time task. J. Neurosci. 22:2002;1905-1913
26. Meneses A. Physiological, pathophysiological and therapeutic roles of 5-HT system in learning and memory. Rev. Neurosci. 9:1998;275-289
27. Michaelis M.L. Drugs targeting Alzheimer's disease: some things old and some things new. J. Pharmacol. Exp. Ther. 304:2003;897-904
28. 3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J. Neurosci. 17:1997;3157-3167
29. 3 binding sites in rat brain cortical membranes. Biochem. Pharmacol. 38:1989;1693-1695
30. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1982;Academic Press, San Diego
31. Perry E.K., Walker M., Grace J., Perry R. Acetylcholine in mind: a neurotransmitter correlate fo consciousness? TINS. 22:1999;273-280
32. Power A.E., Thal L.J., Mcgaugh J.L. Lesions of the nucleus basalis magnocellularis induced by 192 IgG-saporin block memory enhancement with posttraining norepinephrine in the basolateral amygdala. Proc. Natl. Acad Sci. USA. 99:2002;2315-2319
33. 3 receptor blockade in slices from rat entorhinal cortex. Brain Res. 712:1996;274-280
34. Ricceri L., Hohmann C., Berger-Sweeney J. Early neonatal 192 IgG-Saporin induces learning impairments and disrupts cortical morphogenesis in rats. Brain Res. 954:2002;160-172
35. Richter-Levin G., Segal M. Serotonin, aging and cognitive functions of the hippocampus. Rev. Neurosci. 7:1996;103-113
36. Rosenblad C., Nilsson O.G. Basal forebrain grafts in the rat neocortex restore in vivo acetylcholine release and respond to behavioural activation. Neuroscience. 55:1993;353-362
37. Rossner S., Schliebs R., Bigl V. Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions. Brain Res. 668:1994;85-99
38. Rossner S., Schliebs R., Perez-Polo J.R., Wiley R.G., Bigl V. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system. J. Neurosci. Res. 40:1995;31-43
39. Terry A.V., Buccafusco J.J. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 306:2003;821-827
40. Torres E.M., Perry T.A., Blockland A., Wilkinson L.S., Wiley R.G., Lappi D.A., Dunnet S.B. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience. 63:1994;95-122
41. Wainer B.H., Mesulam M.M. Ascending cholinergic pathways in the rat brain. Steriade M., Biesold D. Brain Cholinergic Systems. 1990;65-119 Oxford University Press, Oxford
42. Wang H., Carlier P.R., Ho W.L., Wu D.C., Lee N.T., Li C.P.L., Pang Y.P., Han Y.F. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE. Neuroreport. 10:1999;789-793
43. Wenk G.L., Stoehr J.D., Quintana G., Mobley S., Wiley R.G. Behavioural, biochemical, histological and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J. Neurosci. 14:1994;285-290
44. 3 receptor antagonist and its applications in CNS-related disorders. CNS Drug Rev. 7:2001;199-213